Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23999,82,1.04 [0.49-2.20],0.9179187123580732
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24503,129,0.61 [0.33-1.12],0.1093446342966346
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",24286,886,1.25 [0.99-1.57],0.0558185964909216
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,24526,265,1.69 [1.12-2.54],0.0124811989430425
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23827,2416,1.09 [0.95-1.26],0.2127429168747786
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24055,1831,1.28 [1.09-1.50],0.0021313096534613
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,24346,870,0.84 [0.66-1.06],0.1461931477951008
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,24456,37,0.73 [0.23-2.33],0.5959170100271207
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,23402,562,1.64 [1.24-2.18],0.0005059977138178
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22608,530,1.39 [1.04-1.86],0.0279082773260333
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22838,150,1.85 [1.09-3.15],0.0229311556831786
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18219,1062,1.20 [0.97-1.48],0.0896525314851593
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22627,247,1.17 [0.76-1.80],0.4716664147753218
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,24491,1015,0.87 [0.70-1.08],0.2001419027303819
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Mycoses,24583,322,1.50 [1.03-2.19],0.0326190761727394
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23940,540,1.37 [1.02-1.83],0.0348412262432986
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24532,615,1.52 [1.16-1.99],0.0021826081764088
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23607,131,0.58 [0.32-1.07],0.0817694230320594
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24625,29,1.51 [0.43-5.26],0.5173466167171705
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24460,543,1.67 [1.26-2.22],0.0004033708625992
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24485,66,0.71 [0.31-1.64],0.4273005340593666
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24535,153,1.39 [0.79-2.42],0.2492509325868941
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24521,139,1.50 [0.84-2.68],0.1736247263940259
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23703,303,1.25 [0.85-1.84],0.2603728889488869
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,23608,208,0.85 [0.53-1.37],0.5104635254698393
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,23542,66,1.48 [0.65-3.39],0.3474448408810481
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24598,45,0.94 [0.35-2.49],0.89504406574446
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24568,114,0.76 [0.39-1.46],0.4111944098685288
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Viral warts,24493,39,0.82 [0.27-2.45],0.7231627498344098
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24497,43,0.66 [0.22-1.94],0.449966150251604
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm,24363,280,1.29 [0.86-1.93],0.2199230519827555
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24547,67,0.89 [0.38-2.06],0.7794512154803563
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24520,68,0.94 [0.41-2.17],0.878858820228895
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10987,36,1.14 [0.37-3.49],0.8158003835792891
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",24443,1030,0.81 [0.65-1.00],0.0552839565036204
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of meninges,24614,44,0.62 [0.21-1.77],0.3695436586453876
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24592,48,0.62 [0.23-1.69],0.351861091110651
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24603,81,0.80 [0.37-1.72],0.5643388420843627
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm of ovary,13583,85,1.43 [0.66-3.10],0.3585989615902037
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24617,243,0.99 [0.64-1.54],0.9748029525782048
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Caecum,24613,184,1.01 [0.61-1.67],0.9763335256546628
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24558,49,1.15 [0.43-3.02],0.7836734978050206
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,24619,156,0.74 [0.43-1.28],0.2807669951047878
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Rectum,24586,256,0.89 [0.58-1.38],0.6067221888199341
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24553,479,0.79 [0.57-1.08],0.1403046120161136
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24617,268,0.88 [0.58-1.33],0.5388592012934359
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Carcinoma in situ of breast,11652,74,0.95 [0.41-2.21],0.908914019554648
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11692,85,0.71 [0.32-1.55],0.3893596161475227
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",21243,30,0.85 [0.24-2.96],0.7985435648975854
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",21248,35,1.81 [0.60-5.47],0.2937250216819336
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24585,96,1.71 [0.85-3.42],0.133023657373846
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Haemangioma, any site",24585,94,1.71 [0.84-3.45],0.1363841258246093
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Leiomyoma of uterus,13013,361,0.73 [0.50-1.05],0.0874427670991432
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Lung cancer and mesothelioma,18251,156,2.38 [1.43-3.95],0.0008639266631556
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Lymphoid leukaemia,21238,25,0.35 [0.09-1.39],0.1352367344170965
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",21344,131,0.94 [0.50-1.75],0.8417293079918637
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",21290,77,0.88 [0.39-1.97],0.7555850579546108
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11742,71,1.12 [0.48-2.64],0.7873082480576502
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",21259,46,2.49 [1.05-5.88],0.0380975751177987
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",21267,54,0.73 [0.28-1.89],0.5197190288767672
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",21278,65,1.35 [0.59-3.09],0.4724202052426439
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11721,50,3.33 [1.24-8.97],0.0172850843542832
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",21266,53,1.35 [0.54-3.39],0.5274697219339828
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9898,356,0.80 [0.56-1.14],0.2117229187821662
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",21300,87,1.48 [0.72-3.07],0.2887196893130251
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",21261,48,0.92 [0.34-2.48],0.8657036749505352
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,21270,57,1.38 [0.55-3.47],0.4893943228110766
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanocytic naevi,24417,192,1.41 [0.85-2.34],0.1864940593345082
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanocytic naevi of trunk,24582,87,1.63 [0.78-3.41],0.1983245125435476
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Melanoma in situ,21225,41,0.59 [0.19-1.82],0.3634573238414771
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",21268,55,1.47 [0.60-3.60],0.4050596017051973
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",21317,104,1.07 [0.55-2.09],0.8447892997942849
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",21318,105,2.86 [1.45-5.67],0.0025610820915025
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",21272,59,1.63 [0.68-3.92],0.2748241020117133
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,Other benign neoplasms of skin,24462,130,1.15 [0.63-2.11],0.6477887229462456
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21780,567,0.90 [0.67-1.21],0.4843632755387107
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21809,596,0.92 [0.69-1.23],0.5868303995027002
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,24373,265,1.57 [1.03-2.40],0.0353968828851378
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,23364,43,2.78 [1.06-7.25],0.0369616653422053
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,24174,66,0.85 [0.36-1.97],0.69803239784026
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23906,1973,1.07 [0.92-1.25],0.3752421293009684
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,23588,20,2.06 [0.53-7.96],0.2946679003986349
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,24312,29,2.62 [0.83-8.25],0.1007283801344223
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,24225,904,0.97 [0.78-1.22],0.8232714629755093
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,24225,904,0.97 [0.78-1.22],0.8232714629755093
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,23371,50,0.96 [0.36-2.57],0.9291780325675636
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,24378,810,1.14 [0.89-1.45],0.294163522472842
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,24376,93,1.28 [0.63-2.60],0.4925704975952166
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,24157,49,2.21 [0.89-5.50],0.0883929334800729
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,24146,38,1.71 [0.57-5.07],0.3365448877820013
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24453,170,1.98 [1.20-3.27],0.0076502331246401
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24554,60,0.66 [0.28-1.60],0.3617460435057958
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",24429,146,1.87 [1.08-3.24],0.0260132125806877
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,23628,60,0.95 [0.38-2.39],0.9186778600192772
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21126,178,2.16 [1.39-3.37],0.0006422274945629
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22889,108,1.31 [0.69-2.49],0.402268766015434
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22909,128,2.40 [1.45-3.97],0.000666998126821
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20980,32,2.19 [0.71-6.79],0.1740001586543829
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22851,62,1.43 [0.62-3.34],0.4025321270397713
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,22542,124,1.06 [0.57-1.98],0.8513386907393304
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",24495,143,1.06 [0.60-1.88],0.8353802196099047
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,24399,47,3.52 [1.46-8.49],0.0049845171298984
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,24383,31,1.34 [0.40-4.50],0.6377846888148586
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,24259,1470,1.36 [1.14-1.63],0.0007562398107744
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,22047,1430,1.43 [1.19-1.71],0.0001325846390546
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20987,39,3.21 [1.32-7.81],0.0103767477665877
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",23164,52,1.11 [0.43-2.86],0.8363736235846806
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,21114,166,1.06 [0.62-1.81],0.8229254382288426
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,21001,53,3.05 [1.42-6.57],0.0043708098679172
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,23085,2137,1.12 [0.97-1.29],0.1369513135559963
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,21056,108,1.66 [0.88-3.12],0.1156471737556463
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,21293,345,1.53 [1.07-2.19],0.0206155670474126
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24539,232,0.70 [0.44-1.11],0.1263843105500553
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,24400,93,0.45 [0.22-0.94],0.0332998501437413
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,21039,91,1.61 [0.82-3.18],0.1669578712420731
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20983,35,2.77 [1.00-7.65],0.0491236391188457
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24245,1133,1.03 [0.84-1.27],0.7857042079515704
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21063,115,1.38 [0.75-2.53],0.3009512263505224
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21085,137,1.65 [0.98-2.79],0.0612798499428995
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21298,350,1.43 [1.01-2.01],0.0439639054961804
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,21005,57,1.33 [0.56-3.17],0.5141202117947588
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,24394,87,0.52 [0.24-1.10],0.0881799544287881
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,21219,271,1.67 [1.12-2.48],0.0114983519024395
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,21224,276,1.30 [0.86-1.96],0.207040197515555
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,22470,52,3.02 [1.24-7.38],0.0153740864510306
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24003,3055,1.18 [1.04-1.33],0.0091107676461977
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,23139,27,1.50 [0.40-5.68],0.5489660657787255
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,23165,53,0.75 [0.29-1.96],0.5575611510781779
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24464,1726,1.05 [0.89-1.24],0.5445061981338982
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24466,1722,1.06 [0.90-1.24],0.5107463853349448
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,23144,32,1.46 [0.44-4.83],0.5327315532616477
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,24337,1105,1.36 [1.11-1.68],0.0037267046492989
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21747,799,1.44 [1.14-1.82],0.0022786130341558
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24616,111,1.52 [0.82-2.81],0.1816731053835965
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,24383,31,1.81 [0.59-5.56],0.2982006633468521
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,23314,82,1.92 [0.91-4.02],0.0848302261953647
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,23333,101,0.68 [0.34-1.35],0.2696039696968652
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",21057,109,0.64 [0.32-1.27],0.2023519506757102
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,23017,109,2.59 [1.50-4.48],0.0006355300233625
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1532,60,1.11 [0.46-2.69],0.8111697217680411
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1627,168,0.75 [0.46-1.23],0.2544644684262152
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22945,37,0.66 [0.22-1.98],0.4585621114230117
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1504,32,1.53 [0.51-4.59],0.4469761318798472
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,24260,1352,1.33 [1.12-1.58],0.0013371365093885
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,24414,62,1.40 [0.60-3.26],0.4316209511642654
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22662,244,1.34 [0.87-2.05],0.1865517372679193
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21315,367,1.33 [0.94-1.89],0.1075785854006497
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24543,151,0.50 [0.28-0.87],0.0152123323241143
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23959,49,1.70 [0.70-4.18],0.2440137482816278
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Angina pectoris,23497,713,1.32 [1.03-1.69],0.0271141795281194
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,24003,93,1.32 [0.66-2.62],0.4271439748571993
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23937,27,2.17 [0.77-6.07],0.1413345608840397
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",24003,93,2.00 [1.05-3.83],0.0363688226058
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17488,822,1.24 [0.97-1.59],0.0907182364606813
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,AV-block,22405,163,0.70 [0.41-1.21],0.2029037226437191
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24596,234,1.04 [0.66-1.63],0.8576963998583386
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,16762,96,1.65 [0.82-3.34],0.16328226927096
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,22360,118,0.88 [0.47-1.66],0.6950132225688488
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",22317,75,0.79 [0.35-1.77],0.5646880596749659
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24627,15,0.66 [0.11-3.95],0.6468993041270631
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Conduction disorders,22722,480,1.16 [0.85-1.58],0.3562778740189862
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23974,1199,1.41 [1.16-1.71],0.0004485845681994
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22884,5418,1.10 [1.00-1.21],0.0522301435477589
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23600,159,0.57 [0.33-0.98],0.0439921790949216
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Endocarditis,22283,41,0.47 [0.16-1.39],0.1741164520506797
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24516,460,1.37 [1.01-1.87],0.0436546232711166
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypertension,23390,4409,0.98 [0.88-1.09],0.6872186642857526
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23399,4418,0.98 [0.88-1.08],0.6591409078625987
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24471,47,3.34 [1.58-7.05],0.0015484387757076
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19062,81,5.89 [2.91-11.91],8.016200835693306e-07
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19022,41,0.37 [0.13-1.12],0.0782124633841536
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Hypotension,24538,611,1.48 [1.13-1.95],0.0044171277398068
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,24150,59,0.89 [0.37-2.17],0.8034876751819398
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",24125,1341,1.28 [1.07-1.54],0.0074187708522835
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",24424,279,1.27 [0.85-1.90],0.2406722468367832
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,22430,188,1.46 [0.90-2.36],0.1274169691740394
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,24403,541,1.35 [1.02-1.80],0.0358676871004369
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",23224,440,1.35 [0.99-1.85],0.0614529760231865
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24577,107,2.00 [1.10-3.62],0.0224134636697407
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24613,186,1.28 [0.78-2.08],0.3257616809586455
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,23471,30,4.05 [1.81-9.07],0.0006615809410567
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other aneurysm,23952,42,1.49 [0.53-4.23],0.4489805930963427
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,22467,225,1.07 [0.68-1.69],0.7784977758697034
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23969,59,1.86 [0.84-4.13],0.1280261961759402
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,24043,133,1.15 [0.64-2.07],0.6446686551069926
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,22358,116,2.31 [1.28-4.18],0.0055352562761201
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,23505,64,0.96 [0.40-2.27],0.921329019270308
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,23486,45,0.58 [0.21-1.63],0.3022466905447203
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23924,34,1.10 [0.35-3.47],0.8648948985067035
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,23522,81,0.75 [0.34-1.64],0.4747834481635261
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22767,525,1.08 [0.80-1.45],0.6097861892133583
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23967,40,1.54 [0.55-4.34],0.4089833120788134
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,24220,310,1.82 [1.25-2.64],0.0018422671779848
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,24223,139,2.91 [1.78-4.75],1.9186757877794104e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",24100,210,1.44 [0.91-2.29],0.1222075048446125
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16881,215,1.33 [0.82-2.15],0.2434277512916542
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,24071,183,2.04 [1.29-3.21],0.0021217765936866
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23660,219,0.64 [0.40-1.02],0.0595774893020863
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,24382,298,0.80 [0.54-1.20],0.2848563425004327
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24588,287,1.42 [0.95-2.11],0.0839592840418604
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,22395,153,1.10 [0.64-1.91],0.7275396653588444
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,24220,136,2.87 [1.75-4.72],3.052706756816473e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23994,104,1.58 [0.83-3.01],0.1662987470397744
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",24417,326,1.10 [0.76-1.60],0.6137839895302697
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",24394,360,1.09 [0.76-1.56],0.6418661332621171
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,24130,52,0.99 [0.37-2.63],0.9833328758752826
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23958,49,0.82 [0.31-2.19],0.6874686304361275
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,24264,119,0.70 [0.37-1.33],0.2800180988842992
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,24023,161,1.34 [0.80-2.24],0.2608702223267448
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Varicose veins,23716,275,0.96 [0.63-1.46],0.8522932963276012
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23919,46,2.30 [0.88-6.01],0.0890676311279989
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,24468,463,0.66 [0.48-0.91],0.0115631431812675
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24479,334,1.31 [0.90-1.90],0.1556463267891286
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21929,1268,1.43 [1.18-1.73],0.0003286866581967
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Any mental disorder,23948,3287,1.31 [1.16-1.48],9.979480769486466e-06
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24423,388,1.26 [0.89-1.77],0.1985691745414645
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22161,1500,1.41 [1.18-1.68],0.0001743000807283
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20740,79,1.02 [0.47-2.21],0.9527515978683708
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Smoking dependency,24138,1375,1.36 [1.13-1.63],0.0008419801727339
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22239,1578,1.34 [1.12-1.60],0.0010789176232073
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter V Mental and behavioural disorders,Vascular dementia,24526,18,3.45 [1.20-9.91],0.0217681801898616
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Alzheimer disease,24626,65,2.85 [1.33-6.11],0.0072303907039233
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Bell's palsy,23137,68,2.74 [1.32-5.65],0.0065355107791607
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,23499,430,1.20 [0.86-1.69],0.2783856942281167
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Cerebral cysts,24306,181,1.03 [0.62-1.71],0.9183706162631136
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24547,200,0.93 [0.57-1.51],0.7637741297750742
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,24494,22,1.03 [0.23-4.63],0.9662220788067258
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24615,49,2.03 [0.82-4.99],0.1246995876184068
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",24176,51,2.71 [1.16-6.32],0.0207669727715351
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Epilepsy,23239,235,1.77 [1.15-2.73],0.0099928317600109
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,24191,1187,1.06 [0.87-1.29],0.5917499656129883
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24598,171,0.98 [0.58-1.66],0.9425099978346247
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24175,1479,1.30 [1.08-1.55],0.0046634824340101
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,24290,48,4.60 [2.08-10.15],0.0001613817124388
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Hemiplegia,24493,146,1.08 [0.62-1.90],0.7840931490938245
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Hydrocephalus,24169,44,1.73 [0.64-4.64],0.2794706933658365
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24604,59,1.04 [0.43-2.52],0.9317502604288102
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,23139,70,0.98 [0.41-2.31],0.9581326051025888
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,23140,71,1.49 [0.67-3.31],0.3239324821042151
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Memory loss,24492,64,0.94 [0.39-2.24],0.8897278089097561
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Migraine,23375,371,1.04 [0.72-1.50],0.8398868690494399
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24549,334,1.03 [0.70-1.52],0.8640136688405219
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Motor neuron disease,17906,90,1.33 [0.65-2.73],0.4327260349258248
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24434,134,0.95 [0.52-1.76],0.8786991286981002
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",24085,1016,1.22 [0.98-1.52],0.0725015046915348
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Neurological diseases,23330,2713,1.10 [0.96-1.25],0.1785044771620385
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,24538,66,1.08 [0.47-2.51],0.8507876531355223
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",23419,350,1.04 [0.72-1.50],0.8494555963824897
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24565,207,1.77 [1.13-2.76],0.0122757114213324
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20546,284,1.27 [0.84-1.91],0.2614473566399833
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,24177,52,0.47 [0.18-1.25],0.1307234281834847
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,24231,106,1.39 [0.73-2.66],0.3149523135149829
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,24500,73,1.53 [0.70-3.36],0.2909019077637368
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,23155,86,1.74 [0.86-3.52],0.1201771295502981
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other headache syndromes,23059,55,1.63 [0.66-4.02],0.2896921243489926
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other neurological diseases,24520,395,0.97 [0.69-1.38],0.8764748002076658
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Other sleep disorders,23526,522,0.88 [0.65-1.18],0.3823033915806307
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Parkinson's disease,24613,78,0.79 [0.37-1.71],0.5566422872249626
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,24181,56,0.91 [0.35-2.36],0.8536993779604285
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,24625,34,2.68 [0.88-8.12],0.0815531921445835
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Sleep apnoea,24406,454,0.83 [0.61-1.14],0.2561483133092702
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,24389,31,1.92 [0.58-6.36],0.286505395091877
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24611,115,1.49 [0.79-2.79],0.2180647762198381
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,23096,27,2.18 [0.60-7.95],0.2371334207082638
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24626,66,2.83 [1.32-6.04],0.0072657543617811
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),24514,17,3.61 [1.21-10.71],0.020874702151523
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,24194,36,1.07 [0.34-3.43],0.9049196980178004
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,24302,188,1.04 [0.62-1.72],0.8924182374078349
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24549,171,1.21 [0.74-1.97],0.4453169524131765
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23953,34,1.75 [0.55-5.56],0.3398460958198135
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23987,68,1.16 [0.51-2.65],0.7274833840170767
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24541,29,1.91 [0.57-6.42],0.2968818241095508
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,24454,58,2.58 [1.17-5.69],0.0188065350476575
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1507,35,1.49 [0.52-4.28],0.4619802947992139
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1780,72,1.31 [0.59-2.91],0.5107451094058337
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,24230,72,1.97 [0.92-4.20],0.0792561939887338
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24518,555,1.26 [0.95-1.68],0.1066157303922541
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",24345,426,1.09 [0.78-1.52],0.6199458481499784
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,24041,122,0.92 [0.49-1.73],0.7911881158689117
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24543,429,0.86 [0.61-1.20],0.3651102365972742
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24619,50,2.81 [1.20-6.58],0.0177300164939645
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24474,360,0.76 [0.53-1.11],0.1535970618425008
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24589,193,1.38 [0.85-2.23],0.1872041631843272
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24567,122,0.51 [0.28-0.96],0.0357021050121875
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23934,15,0.91 [0.15-5.38],0.9169906488412052
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23946,27,1.91 [0.55-6.71],0.3109382194766277
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23947,28,0.56 [0.15-2.08],0.3834712471188463
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24584,344,1.10 [0.77-1.58],0.6042134497916227
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,24324,84,1.09 [0.53-2.28],0.8094356694854002
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,24136,22,0.48 [0.11-2.21],0.348457573013037
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,24459,63,1.51 [0.66-3.44],0.3300012302345858
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24528,132,1.57 [0.88-2.80],0.130268162083292
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,24262,148,0.61 [0.35-1.09],0.0964500365926745
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24515,70,0.31 [0.14-0.71],0.0054459858491339
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,24465,225,1.03 [0.66-1.62],0.8896844308530585
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,24257,99,1.10 [0.55-2.18],0.7879202367775437
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23991,964,0.92 [0.74-1.15],0.4689294106681041
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24507,111,1.78 [0.96-3.33],0.0685392195645504
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24604,101,2.52 [1.35-4.69],0.0035788014512731
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,24154,235,1.13 [0.72-1.76],0.6047745450145553
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,24432,36,2.73 [0.99-7.51],0.0519404710793864
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24604,35,2.75 [1.01-7.45],0.0470198178482287
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23955,36,0.55 [0.17-1.77],0.3139778214897329
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,24021,102,0.81 [0.41-1.63],0.5628565470679707
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,24021,58,0.63 [0.26-1.55],0.3165934993966921
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,24164,50,1.60 [0.61-4.24],0.3408443603865638
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",24012,49,1.15 [0.43-3.07],0.7866102470797847
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,24288,48,2.35 [0.88-6.26],0.0873709406233919
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",24322,82,1.38 [0.66-2.86],0.3925874641884925
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23994,75,0.94 [0.43-2.05],0.8698318938389963
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,24071,108,1.15 [0.59-2.25],0.6776870644444668
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23994,31,0.54 [0.16-1.84],0.3251180872447107
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23765,738,1.01 [0.78-1.30],0.9424101343095904
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23964,45,1.19 [0.42-3.32],0.7452694033730038
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,24429,271,1.12 [0.74-1.70],0.5905774004279517
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,24190,32,0.40 [0.12-1.31],0.1305583698565856
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),24272,114,2.11 [1.16-3.84],0.0139544151382975
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,24441,58,0.90 [0.37-2.23],0.8269133390527122
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24585,79,0.99 [0.45-2.19],0.9882559555082556
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24513,126,0.81 [0.43-1.51],0.5044379381671238
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,24435,52,1.32 [0.51-3.42],0.5640466093640799
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,24434,51,2.01 [0.79-5.13],0.1453762434035628
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24543,483,0.90 [0.66-1.23],0.510702340473558
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,24362,302,0.96 [0.65-1.43],0.8469442928309325
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,24148,88,0.62 [0.30-1.29],0.2000175469600945
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,24130,70,1.34 [0.59-3.03],0.486641776202745
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,24363,70,1.78 [0.80-3.98],0.1584147709223871
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24508,215,1.47 [0.92-2.33],0.1040592255808699
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,24351,58,1.67 [0.70-4.02],0.2499028914875309
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,All influenza,23466,70,1.10 [0.48-2.49],0.8218564022453667
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),23465,69,1.07 [0.47-2.43],0.8803927508971575
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),18215,120,0.70 [0.37-1.33],0.2785080089083469
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,24500,282,0.85 [0.56-1.29],0.4415365908182525
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19531,1573,0.83 [0.69-0.99],0.0361904613780229
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19638,1543,0.81 [0.68-0.97],0.0225765616021221
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),24372,86,1.83 [0.89-3.77],0.0989845050537221
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",23447,51,1.79 [0.70-4.55],0.2216857036112824
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Bronchiectasis,21891,159,1.25 [0.72-2.17],0.4184786934255885
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21768,36,1.01 [0.32-3.16],0.9920071040350564
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23835,2103,1.03 [0.88-1.19],0.7379736547240945
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23301,61,0.75 [0.31-1.84],0.535274488371992
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,23390,150,1.37 [0.78-2.40],0.2715947959442858
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24533,648,1.68 [1.30-2.19],8.672211576933291e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,23363,123,1.21 [0.65-2.25],0.5376383387767723
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22886,3791,1.05 [0.94-1.18],0.3788052010624051
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23583,343,0.89 [0.62-1.30],0.558177921958577
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Early onset COPD,24349,464,1.79 [1.32-2.44],0.0002098042422498
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Emphysema,21900,168,1.94 [1.16-3.24],0.0112226077438748
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23472,101,2.36 [1.25-4.47],0.0081103834606184
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,24460,1064,1.25 [1.02-1.54],0.0354219868289816
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,23493,122,1.81 [0.99-3.33],0.0557270302341508
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Later onset COPD,23311,184,1.59 [0.96-2.63],0.0725804402807486
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24619,137,1.23 [0.69-2.19],0.4883465447565025
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Nasal polyp,23346,106,1.00 [0.51-1.95],0.992890698544041
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,24426,563,1.15 [0.86-1.53],0.3563556409870291
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,24463,1117,1.47 [1.21-1.80],0.0001485017371868
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,24041,801,0.92 [0.72-1.17],0.4952776928196899
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other pleural conditions,23379,33,2.22 [0.70-7.00],0.1746533434398622
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24573,180,1.90 [1.16-3.11],0.0103663798006285
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24553,764,1.28 [1.00-1.64],0.0479200069027911
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pleural effusion,23883,537,1.82 [1.38-2.41],2.676537296025847e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pleural plaque,23395,49,1.72 [0.69-4.30],0.2444253141736373
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",24272,876,1.38 [1.10-1.73],0.0058386193246111
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24602,120,1.11 [0.59-2.06],0.7515436504770422
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pneumothorax,23404,58,3.43 [1.53-7.69],0.0028063829608114
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pollen allergy,24595,241,0.95 [0.61-1.49],0.8271738090887281
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,24429,36,2.90 [1.10-7.65],0.0310651855240538
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,18127,32,1.60 [0.51-5.00],0.4220863333976673
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,24406,543,1.14 [0.85-1.53],0.396097835857389
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23522,282,0.84 [0.56-1.28],0.4217913337965232
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Viral pneumonia,23562,166,0.72 [0.42-1.22],0.220802615596043
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",24388,144,0.73 [0.41-1.28],0.2656577088096258
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,14179,86,1.45 [0.69-3.03],0.3236081697729278
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18835,59,1.55 [0.68-3.52],0.2927044094441858
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute appendicitis,24445,136,0.84 [0.46-1.54],0.5735285865953286
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute gastritis,19678,62,1.20 [0.49-2.91],0.6904630290455624
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,23181,152,1.35 [0.78-2.34],0.2787200277151562
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Acute peritonitis,24214,60,0.70 [0.29-1.73],0.4448042852641434
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23935,74,2.07 [0.97-4.44],0.0606984121629269
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,19935,319,0.89 [0.60-1.31],0.5432335859918425
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",23080,51,1.67 [0.67-4.21],0.274410342524079
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",24260,51,1.65 [0.66-4.12],0.2839238997553457
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Cholecystitis,23186,157,1.14 [0.66-1.97],0.6384362886632771
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Cholelithiasis,23871,842,0.94 [0.74-1.20],0.6078588639949842
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Chronic gastritis,19840,224,1.64 [1.04-2.58],0.0325620062313163
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,23068,39,3.22 [1.21-8.52],0.01876206324357
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24499,75,2.78 [1.48-5.22],0.0014336349509167
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Coeliac disease,23349,102,1.14 [0.57-2.29],0.7048194379594741
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Collagenous colitis,23224,48,2.46 [0.97-6.27],0.0586888753212601
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24451,186,0.72 [0.43-1.18],0.1924713724563034
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Constipation,24429,1036,0.93 [0.75-1.15],0.506937169803334
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Crohn disease,23258,82,0.98 [0.45-2.14],0.9668715087312146
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",24310,54,0.75 [0.29-1.97],0.5615349958253006
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,23254,78,0.82 [0.37-1.84],0.6317013626559702
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Dental caries,23884,233,1.08 [0.69-1.68],0.7429651595321689
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22745,1618,0.96 [0.81-1.14],0.6322081856948899
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of appendix,24483,174,0.77 [0.45-1.32],0.3404058781076418
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of liver,24519,658,1.36 [1.05-1.78],0.0208392740282005
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23062,3446,1.13 [1.00-1.27],0.0416858511405204
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",24192,541,1.22 [0.91-1.64],0.183855796656112
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24550,396,1.03 [0.73-1.46],0.8668814961242297
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23767,116,1.13 [0.60-2.13],0.7028973362156536
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23627,61,1.08 [0.46-2.56],0.8601364931131789
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,24373,1126,1.12 [0.92-1.38],0.2658178092257698
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diseases of tongue,23632,109,0.88 [0.45-1.71],0.6984677027012467
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",24165,1136,1.08 [0.88-1.33],0.4514959176934531
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20948,2172,0.83 [0.71-0.96],0.0145381248247107
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,19749,133,1.22 [0.68-2.21],0.5015297007471535
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24560,102,1.53 [0.80-2.92],0.1991689454778945
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24506,72,1.03 [0.45-2.35],0.952342900195848
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23954,93,2.26 [1.20-4.26],0.0114348249287888
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18935,159,0.76 [0.44-1.31],0.3208923336256953
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,20074,458,0.89 [0.64-1.23],0.4694062533172454
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastric ulcer,19874,258,1.16 [0.76-1.79],0.4899608066605724
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21617,2001,1.11 [0.95-1.30],0.1886211501061762
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19989,373,1.13 [0.79-1.61],0.5040654346448901
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,20048,7148,1.01 [0.93-1.10],0.7870742935586423
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,GI-bleeding,24148,901,1.06 [0.84-1.33],0.6454785090722148
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23712,61,1.56 [0.66-3.68],0.3127429952289615
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19581,1135,0.81 [0.66-1.00],0.0485181567697023
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23906,45,3.11 [1.40-6.90],0.0051833399203918
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Hernia,23567,2440,0.99 [0.86-1.14],0.8900683667770796
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Impacted teeth,24516,68,1.08 [0.46-2.52],0.8626003267455794
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Impaction of intestines,18809,33,1.44 [0.43-4.87],0.552899198144234
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Inguinal hernia,21738,611,1.06 [0.81-1.40],0.6717822063091052
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",21200,73,1.50 [0.69-3.27],0.3096561223716417
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18843,67,0.99 [0.42-2.30],0.9775060759154156
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,23368,121,1.03 [0.55-1.95],0.924188206045663
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19290,514,1.00 [0.73-1.37],0.9865130802534672
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24602,340,1.25 [0.86-1.80],0.2396873068481421
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23799,623,1.02 [0.77-1.35],0.8849398060753285
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23960,784,0.93 [0.73-1.20],0.5885807025182931
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19747,131,1.35 [0.75-2.45],0.3189175867440613
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oesophagitis,20054,438,0.82 [0.59-1.14],0.2288323012894051
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24587,121,1.32 [0.70-2.49],0.3861797814521012
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,21172,45,1.31 [0.47-3.61],0.6035209194876769
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19940,1164,0.96 [0.79-1.18],0.7265002308628825
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,23204,175,1.27 [0.76-2.12],0.3652166693725827
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,23174,145,1.05 [0.59-1.88],0.8608797736379301
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,20137,1361,1.05 [0.87-1.27],0.5855931892342628
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,23141,4365,0.95 [0.85-1.05],0.3091140820396768
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23633,176,1.26 [0.74-2.13],0.3889644083043956
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of liver,24390,529,1.43 [1.06-1.91],0.0176226488473705
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20101,485,0.85 [0.62-1.17],0.316947162917559
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,23103,74,0.84 [0.37-1.90],0.6834387418766265
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,24503,349,1.10 [0.76-1.59],0.6245745186556249
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20301,685,1.10 [0.84-1.44],0.4890967899710683
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,24161,914,1.04 [0.83-1.30],0.751017529551899
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23803,152,1.28 [0.74-2.21],0.3842381808278223
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19856,1080,0.96 [0.78-1.19],0.7206952666100473
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21201,1585,1.14 [0.96-1.35],0.1465854682292001
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23936,75,1.56 [0.71-3.41],0.2637620733458413
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23858,682,1.06 [0.81-1.38],0.6833366564912422
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18992,216,1.53 [0.96-2.42],0.0714492322074002
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24491,85,0.88 [0.41-1.89],0.7459687497070959
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19098,322,1.25 [0.85-1.84],0.2528325925661803
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",23372,125,1.71 [0.94-3.11],0.0762933367494337
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24617,55,1.49 [0.59-3.76],0.3943941043276929
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23664,115,1.54 [0.82-2.91],0.1803428871804366
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Toxic colitis,23199,23,2.66 [0.71-9.94],0.1469286820174663
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19788,172,1.49 [0.88-2.51],0.1340708024255378
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,23311,135,0.72 [0.39-1.32],0.2843914288911897
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",23293,117,0.90 [0.47-1.72],0.7483949147963223
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Umbilical hernia,21369,242,0.63 [0.40-0.98],0.039175565044317
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18872,96,1.22 [0.60-2.47],0.5870707390364449
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Ventral hernia,21341,214,1.63 [1.03-2.57],0.0370604105813681
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XI Diseases of the digestive system,Volvulus,18837,61,0.94 [0.38-2.29],0.8882080605117719
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24584,138,1.59 [0.89-2.84],0.1208194768273742
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,24388,75,1.48 [0.68-3.24],0.3276515901617461
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,23297,136,2.29 [1.27-4.14],0.0059476620165607
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,24047,495,1.45 [1.08-1.96],0.0143625886481184
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23734,182,1.51 [0.93-2.45],0.0958455853516906
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,23313,152,1.21 [0.69-2.12],0.4990072561220092
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,24395,209,1.41 [0.88-2.27],0.1506484007800062
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24537,351,1.38 [0.96-1.98],0.0858928616691931
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,24226,40,0.48 [0.16-1.47],0.1992644212081542
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,23309,2297,1.33 [1.16-1.54],8.198396210612295e-05
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,24212,382,1.56 [1.10-2.21],0.0121880585956867
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,24099,269,1.55 [1.02-2.35],0.0382527362215234
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,24262,710,1.39 [1.09-1.79],0.009305054148272
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24615,42,0.90 [0.30-2.64],0.8427112212610612
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,23216,55,0.77 [0.30-1.97],0.5847845038002679
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23867,37,2.16 [0.75-6.19],0.1537601583257318
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,24389,203,1.39 [0.86-2.24],0.1822173357971004
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,23429,268,1.23 [0.80-1.88],0.3455489176529929
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,23194,33,2.43 [0.79-7.46],0.1202044022181365
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24550,66,1.85 [0.84-4.09],0.1286389807378806
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23673,121,1.23 [0.66-2.29],0.5057333584390382
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24448,135,0.99 [0.54-1.81],0.9807783460671996
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,24210,24,1.02 [0.25-4.20],0.9776626244388104
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,23209,48,0.77 [0.27-2.17],0.6214820880824867
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,24162,1001,1.39 [1.12-1.73],0.0028405761209963
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",23459,298,1.37 [0.91-2.04],0.1273692935777082
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,23198,37,2.09 [0.71-6.21],0.182696871448599
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24552,239,0.98 [0.62-1.53],0.9127827800304578
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,24240,54,3.30 [1.41-7.70],0.0058187093615501
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24508,195,0.96 [0.58-1.58],0.8715198014338392
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24599,153,1.53 [0.88-2.67],0.1354661544781948
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,23275,114,2.05 [1.07-3.95],0.03119710538036
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,23336,175,0.78 [0.46-1.34],0.3722604052671842
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24593,147,1.58 [0.90-2.78],0.1109083521957686
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",23277,116,1.94 [1.08-3.48],0.0269102309139596
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24595,111,1.60 [0.84-3.03],0.1498753071967209
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,21584,121,1.04 [0.55-1.97],0.8969880537210838
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22963,4173,1.06 [0.95-1.18],0.3312367433999647
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21747,2957,1.14 [1.00-1.29],0.051933696213169
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,21550,87,0.78 [0.37-1.65],0.5185711954431553
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,22061,139,1.43 [0.80-2.54],0.2255496234287982
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,22066,144,1.47 [0.83-2.60],0.1817820320273137
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,24418,108,1.82 [0.97-3.44],0.0641996764127062
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21965,43,0.76 [0.44-1.32],0.3252063602948329
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19474,684,1.28 [0.98-1.68],0.0702149570706263
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24568,116,1.12 [0.59-2.16],0.7260955730784144
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,22180,258,0.95 [0.61-1.47],0.8099278189102517
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21509,5596,1.03 [0.94-1.13],0.5454697030065576
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,23373,99,1.50 [0.76-2.96],0.2397455909045413
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,21573,110,0.58 [0.30-1.13],0.1115907374712635
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,22020,557,0.83 [0.61-1.11],0.2129749446979452
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23812,1890,1.01 [0.86-1.18],0.9046624356405432
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21671,208,0.93 [0.57-1.51],0.7586364264343871
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21728,265,1.43 [0.93-2.21],0.1008727697903251
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21601,138,0.73 [0.40-1.33],0.3001404430126898
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,24143,35,0.97 [0.30-3.18],0.9599497480732662
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19962,1172,1.07 [0.88-1.31],0.4975988571088854
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,19138,348,1.07 [0.74-1.55],0.709137116651297
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24577,338,1.07 [0.74-1.53],0.7318691208677954
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18859,69,0.83 [0.35-1.97],0.6802356641520115
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19105,315,0.91 [0.61-1.37],0.649937697513953
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21761,298,1.11 [0.75-1.67],0.5975267826006585
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19478,688,0.99 [0.76-1.29],0.9156866574385568
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21947,25,0.83 [0.20-3.44],0.7965706782672075
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,22425,503,0.84 [0.61-1.14],0.260100403490518
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,22179,257,1.21 [0.79-1.87],0.3854704340311683
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19427,637,0.93 [0.71-1.23],0.608882764860176
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,21533,70,1.06 [0.47-2.42],0.8808564303702998
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",21517,54,0.87 [0.34-2.25],0.7768487200423799
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,23328,54,1.19 [0.48-2.95],0.7004473162620279
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24325,1051,1.27 [1.03-1.58],0.0288538842028589
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23870,596,1.14 [0.85-1.53],0.3798222780616891
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24518,310,1.56 [1.06-2.29],0.0249789599932077
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,20390,1600,1.23 [1.04-1.47],0.0185137514378769
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18857,67,0.45 [0.19-1.06],0.0673072095784849
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,21534,71,0.89 [0.39-2.03],0.7796304345854443
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18816,26,2.37 [0.65-8.62],0.190395383648998
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18892,102,1.91 [0.95-3.83],0.0675325528703019
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,23487,213,1.35 [0.84-2.15],0.2144373630517088
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,23498,224,1.77 [1.10-2.83],0.0175878963800182
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24590,78,1.68 [0.79-3.57],0.1805176519235944
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",23330,1408,1.04 [0.87-1.26],0.6416305966742146
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21574,111,2.04 [1.07-3.86],0.0292172353728462
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18904,114,1.37 [0.71-2.67],0.3508932113022148
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,22493,571,1.14 [0.85-1.52],0.3748773323404898
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20629,1839,0.98 [0.83-1.15],0.7911599393551376
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,24162,54,1.34 [0.52-3.44],0.5450513698379391
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24601,71,1.39 [0.62-3.13],0.420467833255213
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21532,69,1.70 [0.76-3.81],0.1989163825399689
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",22453,990,1.11 [0.89-1.39],0.3384006679992745
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,21526,63,0.80 [0.33-1.91],0.6094460754173546
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19798,1008,1.28 [1.03-1.59],0.0288270612002722
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,23372,98,0.76 [0.37-1.53],0.4346892747734037
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,21521,58,1.18 [0.47-2.93],0.7264261178073341
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,22027,105,1.08 [0.54-2.13],0.8352954137358277
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21818,355,1.00 [0.69-1.43],0.9814518102738538
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,24300,192,1.55 [0.94-2.57],0.0855094199825878
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,22346,424,1.18 [0.85-1.64],0.3255586439051437
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24527,294,1.53 [1.03-2.28],0.0360930768353132
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24609,34,1.22 [0.37-4.03],0.7473458947336895
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21651,188,0.75 [0.45-1.26],0.2809212933431746
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19735,552,1.02 [0.75-1.37],0.920895256188021
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21905,442,0.91 [0.65-1.26],0.5567693900628985
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21617,154,1.48 [0.85-2.59],0.1668424772416303
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18824,34,1.60 [0.50-5.13],0.4311365667010979
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,20378,1588,1.25 [1.05-1.49],0.0117802841980617
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19196,406,1.49 [1.06-2.10],0.0232591844082761
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,24188,80,1.75 [0.83-3.70],0.1434751478944415
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24557,45,2.51 [0.99-6.39],0.0524807343592844
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",23185,26,0.88 [0.23-3.40],0.85764391934465
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18863,73,1.48 [0.66-3.29],0.3422437287341467
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,22004,82,0.79 [0.36-1.70],0.5406282707619063
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19104,314,1.54 [1.04-2.27],0.0315782969778039
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21706,243,1.33 [0.86-2.04],0.1981440123762501
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,22114,192,1.09 [0.66-1.81],0.7230248992493016
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,22017,95,1.02 [0.49-2.12],0.9541713003222768
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20806,43,2.85 [1.02-8.01],0.0465992704566923
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24612,37,1.51 [0.49-4.66],0.4748128649816275
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,22004,541,1.18 [0.88-1.59],0.2661475858730596
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],24186,78,1.24 [0.55-2.76],0.6040661976854442
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23658,2195,0.99 [0.85-1.15],0.8891706202645469
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21565,102,1.02 [0.51-2.04],0.9580629336481208
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,22250,328,0.84 [0.57-1.24],0.3821173689750021
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,23350,172,0.91 [0.53-1.54],0.7192455962930735
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,22056,134,1.15 [0.63-2.10],0.6429614908918959
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22893,971,0.97 [0.78-1.22],0.8240560448020403
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,22560,638,1.03 [0.78-1.36],0.8218435797644956
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],21503,40,1.41 [0.49-4.09],0.5284565423352403
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,24250,142,1.10 [0.61-1.99],0.7392684298996254
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21603,140,0.67 [0.37-1.23],0.1960154857097674
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,21517,54,1.19 [0.45-3.12],0.7247547979324198
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18822,32,1.94 [0.61-6.17],0.2631304593281989
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24158,756,1.45 [1.14-1.84],0.0022765480060288
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9992,64,0.71 [0.30-1.71],0.4506080620090439
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13297,74,1.15 [0.50-2.64],0.7472197867648842
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24357,279,1.23 [0.82-1.84],0.3169766004676714
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,24135,57,0.90 [0.36-2.22],0.8173197424717565
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23971,569,1.22 [0.92-1.62],0.1598691148476317
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24463,20,1.64 [0.38-7.14],0.5100266027452122
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,24474,165,1.32 [0.79-2.22],0.2882320670132633
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Cystitis,22620,139,1.10 [0.61-1.99],0.7555672804282281
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Dialysis,23445,43,1.07 [0.39-2.95],0.9013341844399168
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10649,1020,1.00 [0.81-1.24],0.9722032090406968
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13402,179,1.66 [0.97-2.82],0.0635818357417212
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,10044,116,0.92 [0.48-1.78],0.813867881245105
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10267,339,0.66 [0.45-0.97],0.0353012881692798
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10312,384,0.85 [0.59-1.23],0.3963966816975975
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20761,3801,1.09 [0.98-1.22],0.1283993320849115
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24502,59,1.89 [0.83-4.29],0.1266663124954949
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,9703,74,1.15 [0.52-2.53],0.7282825453899306
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,23323,200,0.99 [0.61-1.60],0.9538666119863762
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10311,682,1.00 [0.77-1.29],0.9915577942287166
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13281,211,1.35 [0.83-2.20],0.227695483283656
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9721,92,1.72 [0.87-3.41],0.119656316961142
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,13292,109,0.32 [0.16-0.61],0.0006132496055109
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10193,265,0.89 [0.58-1.37],0.5932324832149077
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22539,58,0.58 [0.23-1.47],0.2539826818753708
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11188,1260,0.90 [0.73-1.10],0.2865700286926198
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9675,46,1.24 [0.47-3.30],0.662336528301916
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,10016,88,0.81 [0.38-1.73],0.5886013325443541
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24616,37,1.67 [0.55-5.06],0.3636794020917412
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24621,41,0.53 [0.17-1.59],0.2555014774540195
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23844,1363,1.10 [0.91-1.33],0.3125919869431896
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22911,430,1.49 [1.08-2.06],0.0152965519043709
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,13278,55,1.61 [0.61-4.27],0.3379830214910022
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24580,271,1.08 [0.71-1.63],0.7299472392481128
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9769,140,0.54 [0.30-0.96],0.0370709460397508
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9736,107,1.80 [0.98-3.30],0.057172991497956
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9696,67,0.77 [0.34-1.76],0.5327268598459767
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24592,49,0.97 [0.35-2.66],0.9512323367670156
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,23480,999,1.12 [0.90-1.40],0.3009276027539783
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,13179,109,1.71 [0.87-3.35],0.1165825357858585
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,10002,74,1.19 [0.52-2.72],0.6828224519335082
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",10137,209,1.00 [0.61-1.63],0.9975621147483412
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9982,54,1.00 [0.37-2.69],0.9968043384752264
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,10022,94,0.63 [0.30-1.30],0.2088235763209439
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,23353,230,1.05 [0.67-1.66],0.8231144174348438
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,24402,93,0.95 [0.47-1.95],0.8959854972605027
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,10089,161,1.27 [0.72-2.23],0.4145244198659303
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9999,71,1.09 [0.46-2.56],0.8489805975011067
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10305,377,0.99 [0.69-1.43],0.9583307332056022
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9987,59,0.67 [0.27-1.70],0.4017017102200851
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10263,335,1.21 [0.82-1.78],0.3357905556046293
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24485,42,1.31 [0.46-3.72],0.6116105189906491
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9728,99,2.18 [1.15-4.13],0.0175232797102985
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24463,1340,1.31 [1.09-1.58],0.0035232525575564
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",23248,125,2.63 [1.48-4.67],0.0009747855252925
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,23462,60,0.48 [0.20-1.18],0.1109414216226228
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,24140,62,1.85 [0.83-4.14],0.131976295106719
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22635,154,0.91 [0.53-1.59],0.7495653814291461
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24416,338,1.36 [0.95-1.96],0.0935145641218074
GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,10017,89,1.15 [0.54-2.45],0.7088791806908239
